Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.95 EUR | -0.42% | -3.63% | -6.27% |
Mar. 14 | Hyloris Pharmaceuticals SA Provides Earnings Guidance for 2024 | CI |
Mar. 14 | Transcript : Hyloris Pharmaceuticals SA, 2023 Earnings Call, Mar 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.27% | 356M | |
+28.79% | 676B | |
+24.81% | 554B | |
-7.64% | 349B | |
+15.00% | 318B | |
+5.99% | 291B | |
+2.47% | 210B | |
-0.02% | 204B | |
-9.98% | 194B | |
-11.71% | 144B |
- Stock Market
- Equities
- HYL Stock
- News Hyloris Pharmaceuticals SA
- Hyloris Pharmaceuticals Develops New Treatment For Idiopathic Rhinitis